Abstract
Among all Bcl2 homology domain 3 (BH3)-only proteins known to date, APR/PMAIP1/Noxa, albeit showing weak proapoptotic potential on its own, appears to be crucial in fine-tuning cell death decisions by targeting the prosurvival molecule Mcl1 for proteasomal degradation. This event appears critical for cell death induction along the mitochondrial Bcl2-regulated apoptosis pathway in response to factor deprivation or DNA damage, presumably by sensitizing the cell toward the action of additional BH3-only protein family members. This review aims to summarize the function of Noxa in normal physiology, stress-induced cell death and tumorigenesis.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Alves NL, Derks IA, Berk E, Spijker R, van Lier RA, Eldering E . (2006). The Noxa/Mcl-1 axis regulates susceptibility to apoptosis under glucose limitation in dividing T cells. Immunity 24: 703–716.
Bauer A, Villunger A, Labi V, Fischer SF, Strasser A, Wagner H et al. (2006). The NF-kappaB regulator Bcl-3 and the BH3-only proteins Bim and Puma control the death of activated T cells. Proc Natl Acad Sci USA 103: 10979–10984.
Chen L, Willis SN, Wei A, Smith BJ, Fletcher JI, Hinds MG et al (2005). Differential targeting of prosurvival Bcl-2 proteins by their BH3-only ligands allows complementary apoptotic function. Mol Cell 17: 393–403.
Coultas L, Huang DC, Adams JM, Strasser A . (2002). Pro-apoptotic BH3-only Bcl-2 family members in vertebrate model organisms suitable for genetic experimentation. Cell Death Differ 9: 1163–1166.
Craig RW . (2002). MCL1 provides a window on the role of the BCL2 family in cell proliferation, differentiation and tumorigenesis. Leukemia 16: 444–454.
Czabotar PE, Lee EF, van Delft MF, Day CL, Smith BJ, Huang DC et al. (2007). Structural insights into the degradation of Mcl-1 induced by BH3 domains. Proc Natl Acad Sci USA 104: 6217–6222.
Eferl R, Ricci R, Kenner L, Zenz R, David JP, Rath M et al. (2003). Liver tumor development. c-Jun antagonizes the proapoptotic activity of p53. Cell 112: 181–192.
Fei P, Bernhard EJ, El-Deiry WS . (2002). Tissue-specific induction of p53 targets in vivo. Cancer Res 62: 7316–7327.
Fernandez Y, Verhaegen M, Miller TP, Rush JL, Steiner P, Opipari AW et al. (2005). Differential regulation of noxa in normal melanocytes and melanoma cells by proteasome inhibition: therapeutic implications. Cancer Res 65: 6294–6304.
Flinterman M, Guelen L, Ezzati-Nik S, Killick R, Melino G, Tominaga K et al. (2005). E1A activates transcription of p73 and Noxa to induce apoptosis. J Biol Chem 280: 5945–5959.
Garrison SP, Jeffers JR, Yang C, Nilsson JA, Hall MA, Rehg JE et al. (2008). Selection against PUMA gene expression in Myc-driven B-cell lymphomagenesis. Mol Cell Biol 28: 5391–5402.
Hallaert DY, Spijker R, Jak M, Derks IA, Alves NL, Wensveen FM et al. (2007). Crosstalk among Bcl-2 family members in B-CLL: seliciclib acts via the Mcl-1/Noxa axis and gradual exhaustion of Bcl-2 protection. Cell Death Differ 14: 1958–1967.
Hemann MT, Zilfou JT, Zhao Z, Burgess DJ, Hannon GJ, Lowe SW . (2004). Suppression of tumorigenesis by the p53 target PUMA. Proc Natl Acad Sci USA 101: 9333–9338.
Hershko T, Ginsberg D . (2004). Up-regulation of Bcl-2 homology 3 (BH3)-only proteins by E2F1 mediates apoptosis. J Biol Chem 279: 8627–8634.
Hijikata M, Kato N, Sato T, Kagami Y, Shimotohno K . (1990). Molecular cloning and characterization of a cDNA for a novel phorbol-12-myristate-13-acetate-responsive gene that is highly expressed in an adult T-cell leukemia cell line. J Virol 64: 4632–4639.
Huntington ND, Puthalakath H, Gunn P, Naik E, Michalak EM, Smyth MJ et al. (2007). Interleukin 15-mediated survival of natural killer cells is determined by interactions among Bim, Noxa and Mcl-1. Nat Immunol 8: 856–863.
Inoue S, Riley J, Gant TW, Dyer MJ, Cohen GM . (2007). Apoptosis induced by histone deacetylase inhibitors in leukemic cells is mediated by Bim and Noxa. Leukemia 21: 1773–1782.
Jansson AK, Emterling AM, Arbman G, Sun XF . (2003). Noxa in colorectal cancer: a study on DNA, mRNA and protein expression. Oncogene 22: 4675–4678.
Kim JY, Ahn HJ, Ryu JH, Suk K, Park JH . (2004). BH3-only protein Noxa is a mediator of hypoxic cell death induced by hypoxia-inducible factor 1alpha. J Exp Med 199: 113–124.
Konopleva M, Watt J, Contractor R, Tsao T, Harris D, Estrov Z et al. (2008). Mechanisms of antileukemic activity of the novel Bcl-2 homology domain-3 mimetic GX15-070 (Obatoclax). Cancer Res 68: 3413–3420.
Labi V, Grespi F, Baumgartner F, Villunger A . (2008). Targeting the Bcl-2-regulated apoptosis pathway by BH3 mimetics: a breakthrough in anticancer therapy? Cell Death Differ 15: 977–987.
Lau LM, Nugent JK, Zhao X, Irwin MS . (2008). HDM2 antagonist Nutlin-3 disrupts p73-HDM2 binding and enhances p73 function. Oncogene 27: 997–1003.
Lee SH, Soung YH, Lee JW, Kim HS, Lee JH, Kim HS et al. (2003). Mutational analysis of Noxa gene in human cancers. APMIS 111: 599–604.
Lin X, Morgan-Lappe S, Huang X, Li L, Zakula DM, Vernetti LA et al. (2007). ‘Seed’ analysis of off-target siRNAs reveals an essential role of Mcl-1 in resistance to the small-molecule Bcl-2/Bcl-XL inhibitor ABT-737. Oncogene 26: 3972–3979.
Liu G, Parant JM, Lang G, Chau P, Chavez-Reyes A, El-Naggar AK et al. (2004). Chromosome stability, in the absence of apoptosis, is critical for suppression of tumorigenesis in Trp53 mutant mice. Nat Genet 36: 63–68.
Liu X, Dai S, Zhu Y, Marrack P, Kappler JW . (2003). The structure of a Bcl-xL/Bim fragment complex: implications for Bim function. Immunity 19: 341–352.
Mackus WJ, Kater AP, Grummels A, Evers LM, Hooijbrink B, Kramer MH et al. (2005). Chronic lymphocytic leukemia cells display p53-dependent drug-induced Puma upregulation. Leukemia 19: 427–434.
Mei Y, Du W, Yang Y, Wu M . (2005). Puma(*)Mcl-1 interaction is not sufficient to prevent rapid degradation of Mcl-1. Oncogene 24: 7224–7237.
Mestre-Escorihuela C, Rubio-Moscardo F, Richter JA, Siebert R, Climent J, Fresquet V et al. (2007). Homozygous deletions localize novel tumor suppressor genes in B-cell lymphomas. Blood 109: 271–280.
Michalak EM, Jansen ES, Happo L, Cragg MS, Tai L, Smyth GK et al. (2009). Puma and to a lesser extent Noxa are suppressors of Myc-induced lymphomagenesis. Cell Death Differ; (e-pub ahead of print 16 January 2009).
Michalak EM, Villunger A, Adams JM, Strasser A . (2008). In several cell types tumour suppressor p53 induces apoptosis largely via Puma but Noxa can contribute. Cell Death Differ 15: 1019–1029.
Morales AA, Gutman D, Lee KP, Boise LH . (2008). BH3-only proteins Noxa, Bmf, and Bim are necessary for arsenic trioxide-induced cell death in myeloma. Blood 111: 5152–5162.
Naik E, Michalak EM, Villunger A, Adams JM, Strasser A . (2007). Ultraviolet radiation triggers apoptosis of fibroblasts and skin keratinocytes mainly via the BH3-only protein Noxa. J Cell Biol 176: 415–424.
Nijhawan D, Fang M, Traer E, Zhong Q, Gao W, Du F et al. (2003). Elimination of Mcl-1 is required for the initiation of apoptosis following ultraviolet irradiation. Genes Dev 17: 1475–1486.
Nikiforov MA, Riblett M, Tang WH, Gratchouck V, Zhuang D, Fernandez Y et al. (2007). Tumor cell-selective regulation of NOXA by c-MYC in response to proteasome inhibition. Proc Natl Acad Sci USA 104: 19488–19493.
Oda E, Ohki R, Murasawa H, Nemoto J, Shibue T, Yamashita T et al. (2000). Noxa, a BH3-only member of the Bcl-2 family and candidate mediator of p53-induced apoptosis. Science 288: 1053–1058.
Olejniczak ET, Van SC, Anderson MG, Wang G, Tahir SK, Sauter G et al. (2007). Integrative genomic analysis of small-cell lung carcinoma reveals correlates of sensitivity to bcl-2 antagonists and uncovers novel chromosomal gains. Mol Cancer Res 5: 331–339.
Oltersdorf T, Elmore SW, Shoemaker AR, Armstrong RC, Augeri DJ, Belli BA et al. (2005). An inhibitor of Bcl-2 family proteins induces regression of solid tumours. Nature 435: 677–681.
Opferman JT, Letai A, Beard C, Sorcinelli MD, Ong CC, Korsmeyer SJ . (2003). Development and maintenance of B and T lymphocytes requires antiapoptotic MCL-1. Nature 426: 671–676.
Ploner C, Rainer J, Niederegger H, Eduardoff M, Villunger A, Geley S et al. (2008). The BCL2 rheostat in glucocorticoid-induced apoptosis of acute lymphoblastic leukemia. Leukemia 22: 370–377.
Qin JZ, Ziffra J, Stennett L, Bodner B, Bonish BK, Chaturvedi V et al. (2005). Proteasome inhibitors trigger NOXA-mediated apoptosis in melanoma and myeloma cells. Cancer Res 65: 6282–6293.
Schmidt S, Rainer J, Riml S, Ploner C, Jesacher S, Achmüller C et al. (2006). Identification of glucocorticoid-response genes in children with acute lymphoblastic leukemia. Blood 107:2061–2069.
Schuler M, Maurer U, Goldstein JC, Breitenbucher F, Hoffarth S, Waterhouse NJ et al. (2003). p53 triggers apoptosis in oncogene-expressing fibroblasts by the induction of Noxa and mitochondrial Bax translocation. Cell Death Differ 10: 451–460.
Seo YW, Shin JN, Ko KH, Cha JH, Park JY, Lee BR et al. (2003). The molecular mechanism of Noxa-induced mitochondrial dysfunction in p53-mediated cell death. J Biol Chem 278: 48292–48299.
Shibue T, Suzuki S, Okamoto H, Yoshida H, Ohba Y, Takaoka A et al. (2006). Differential contribution of Puma and Noxa in dual regulation of p53-mediated apoptotic pathways. EMBO J 25: 4952–4962.
Shibue T, Takeda K, Oda E, Tanaka H, Murasawa H, Takaoka A et al. (2003). Integral role of Noxa in p53-mediated apoptotic response. Genes Dev 17: 2233–2238.
Sinicrope FA, Rego RL, Okumura K, Foster NR, O′Connell MJ, Sargent DJ et al. (2008). Prognostic impact of bim, puma, and noxa expression in human colon carcinomas. Clin Cancer Res 14: 5810–5818.
Tahir SK, Yang X, Anderson MG, Morgan-Lappe SE, Sarthy AV, Chen J et al. (2007). Influence of Bcl-2 family members on the cellular response of small-cell lung cancer cell lines to ABT-737. Cancer Res 67: 1176–1183.
Tournier C, Hess P, Yang DD, Xu J, Turner TK, Nimnual A et al. (2000). Requirement of JNK for stress-induced activation of the cytochrome c-mediated death pathway. Science 288: 870–874.
van Delft MF, Wei AH, Mason KD, Vandenberg CJ, Chen L, Czabotar PE et al. (2006). The BH3 mimetic ABT-737 targets selective Bcl-2 proteins and efficiently induces apoptosis via Bak/Bax if Mcl-1 is neutralized. Cancer Cell 10: 389–399.
Villunger A, Michalak EM, Coultas L, Mullauer F, Bock G, Ausserlechner MJ et al. (2003). p53- and drug-induced apoptotic responses mediated by BH3-only proteins puma and noxa. Science 302: 1036–1038.
Wang H, Wang L, Erdjument-Bromage H, Vidal M, Tempst P, Jones RS et al. (2004). Role of histone H2A ubiquitination in polycomb silencing. Nature 431: 873–878.
Wang Z, Sun Y . (2008). Identification and characterization of two splicing variants of human Noxa. Anticancer Res 28: 1667–1674.
Willis SN, Chen L, Dewson G, Wei A, Naik E, Fletcher JI et al. (2005). Proapoptotic Bak is sequestered by Mcl-1 and Bcl-xL, but not Bcl-2, until displaced by BH3-only proteins. Genes Dev 19: 1294–1305.
Yamashita M, Kuwahara M, Suzuki A, Hirahara K, Shinnaksu R, Hosokawa H et al. (2008). Bmi1 regulates memory CD4T cell survival via repression of the Noxa gene. J Exp Med 205: 1109–1120.
Zhong Q, Gao W, Du F, Wang X . (2005). Mule/ARF-BP1, a BH3-only E3 ubiquitin ligase, catalyzes the polyubiquitination of Mcl-1 and regulates apoptosis. Cell 121: 1085–1095.
Acknowledgements
The work in our laboratories was supported by fellowships and grants from the Austrian Science Fund (FWF): Y212-B13 START, the Doctoral College MCBO, the SFB021, projects P18747 and P18571, the Association for International Cancer Research (AICR), EU-FP7 (ApopTrain) and the Tyrolean Science Fund (TWF). We apologize to the many scientists in this field whose excellent research was not cited but was only referred to indirectly through reviews.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ploner, C., Kofler, R. & Villunger, A. Noxa: at the tip of the balance between life and death. Oncogene 27 (Suppl 1), S84–S92 (2008). https://doi.org/10.1038/onc.2009.46
Published:
Issue Date:
DOI: https://doi.org/10.1038/onc.2009.46
Keywords
This article is cited by
-
The p53 reactivator PRIMA-1MET synergises with 5-fluorouracil to induce apoptosis in pancreatic cancer cells
Investigational New Drugs (2023)
-
Targeting multifunctional magnetic nanowires for drug delivery in cancer cell death: an emerging paradigm
Environmental Science and Pollution Research (2023)
-
BCL-2 protein family: attractive targets for cancer therapy
Apoptosis (2023)
-
The BCL-2 inhibitor ABT-199/venetoclax synergizes with proteasome inhibition via transactivation of the MCL-1 antagonist NOXA
Cell Death Discovery (2022)
-
Artesunate improves venetoclax plus cytarabine AML cell targeting by regulating the Noxa/Bim/Mcl-1/p-Chk1 axis
Cell Death & Disease (2022)